Evaluating Guideline‐recommended Pain Medication Use Among Patients with Newly Diagnosed Fibromyalgia

Abstract

Opioid use was widespread among patients with FM. Once patients received opioids postdiagnosis, the likelihood of receiving guideline-recommended medications was small. These real-world results indicate an opportunity may exist for improved FM management using recommended therapies in clinical practice.